In human endothelial cells, quercetin or its metabolite isorhamnetin inhibit the expression of biomarkers of endothelial dysfunction including VCAM-1, ICAM-1 and MCP-1 at a physiologically attainable concentration of 2 μM [121]. Here, VCAM1 is linked to endothelial dysfunction.